Sinoviortesis con radioisótopos en hemofilia: Experiencia de un centro en Chile / Radionuclide synoviorthesis in hemophilia: experience in 107 patients
Rev. méd. Chile
; 147(5): 568-573, mayo 2019. tab, graf
Article
en Es
| LILACS
| ID: biblio-1014265
Biblioteca responsable:
CL1.1
ABSTRACT
Background:
In patients with hemophilia, radionuclide synoviorthesis, or the intra-articular injection of a radionuclide to decrease the synovial hypertrophy tissue, aims to decrease or avoid hemarthrosis.Aim:
To evaluate the effectiveness of radionuclide synoviorthesis in hemophilia. Material andMethods:
Observational retrospective study of the evolution of 107 male patients aged 3 to 54 years who were subjected to radionuclide synoviorthesis between 2007 and 2015.Results:
Of 164 treated joints, in 65% treatment was successful, (defined as zero to two hemarthroses and absence of synovitis during the follow up period), in 17% it was partially successful (defined as two or less hemarthroses, but persistence of the synovitis) and failed in 18% of the procedures. No important complications were recorded.Conclusions:
Radionuclide synoviorthesis has an overall 82% success rate, is minimally invasive, can be used at any age and is inexpensive We recommend its implementation in Chilean hemophilia treatment centers.Palabras clave
Texto completo:
1
Índice:
LILACS
Asunto principal:
Radioisótopos
/
Renio
/
Sinovitis
/
Radioisótopos de Itrio
/
Hemartrosis
/
Hemofilia A
Tipo de estudio:
Observational_studies
Límite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
/
Male
País/Región como asunto:
America do sul
/
Chile
Idioma:
Es
Revista:
Rev. méd. Chile
Asunto de la revista:
MEDICINA
Año:
2019
Tipo del documento:
Article